Skip to main content

Advertisement

Table 2 Clinical Characteristics and presence of comorbidities

From: Profile and factors associated with glycaemic control of patients with type 2 diabetes in Greece: results from the diabetes registry

Clinical characteristics
Family history of diabetes (N, %; Yes)555 (48.6)
T2DM duration
 0–6 months109 (9.6)
 6 months to 5 years351 (30.8)
 6–10 years217 (19.0)
  ≥ 10 years464 (40.7)
Dyslipidemia (N, %; Yes)702 (61.5)
Hypertension (N, %; Yes)682 (59.8)
Treatment modality (N, %)
 Diet and exercise58 (5.1)
 Oral antidiabetic agents only773 (67.7)
 Injectable antidiabetic agents only131 (11.5)
 Combination of oral and injectable antidiabetic agents180 (15.8)
No. of antidiabetic agents used (N, %)
 1719 (66.3)
 2279 (25.7)
  ≥ 386 (7.9)
Hyperthyroid (N, %; Yes)21 (1.8)
Hypothyroid (N, %; Yes)182 (16.0)
Coronary artery disease (N, %; Yes)247 (21.6)
Heart failure (N, %; Yes)94 (8.2)
Atrial fibrillation (N, %; Yes)94 (8.2)
Stroke (N, %; Yes)53 (4.6)
Transient ischemic attach (N, %; Yes)50 (4.4)
Peripheral arterial disease (N, %; Yes)73 (6.4)
Peripheral neuropathy (N, %; Yes)74 (6.5)
Erectile dysfunction (N, %; Yes)6 (0.5)
Diabetic foot (N, %; Yes)25 (2.2)
Retinopathy (N, %; Yes)57 (5)
eGFRa (Mean ± SD; ml/min/1.73m2)67.70 ± 17.05
  1. CKD chronic kidney disease, eGFR estimated glomerular filtration rate, T2DM type 2 diabetes mellitus
  2. aEstimated using CKD-EPI equation